In this study, lorlatinib does not cause P‐gp expression to increase in rat brain tissue, which indicates that lorlatinib is not isolated from the brain by P‐gp and will not lose the opportunity to inhibit cancer cell growth in brain tissue due to drug efflux. This evidence concerns the gene PGP and cancer.